These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4355755)
1. Acid liability of rhinovirus type 14: effect of pH, time, and temperature. Hughes JH; Thomas DC; Hamparian VV; Cramblett HG Proc Soc Exp Biol Med; 1973 Nov; 144(2):555-60. PubMed ID: 4355755 [No Abstract] [Full Text] [Related]
2. [Stabilization of the infectious activity of rhinovirus in prolonged storage]. Tsareva AA; Fadeeva LL; Dreĭzin RS Vopr Virusol; 1974; (5):550-6. PubMed ID: 4373933 [No Abstract] [Full Text] [Related]
3. Infectivity and sedimentation of rhinovirus ribonucleic acid. Nair CN; Lonberg-Holm KK J Virol; 1971 Feb; 7(2):278-80. PubMed ID: 4329400 [TBL] [Abstract][Full Text] [Related]
4. The effects of concanavalin A on the early events of infection by rhinovirus type 2 and poliovirus type 2. Lonberg-Holm K J Gen Virol; 1975 Sep; 28(3):313-27. PubMed ID: 170375 [TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of scillarenin, a plant bufadienolide. Sato N; Muro T Jpn J Microbiol; 1974 Nov; 18(6):441-8. PubMed ID: 4375728 [No Abstract] [Full Text] [Related]
6. Characterization of type 1 poliovirus by electrophoretic analysis. Mandel B Virology; 1971 Jun; 44(3):554-68. PubMed ID: 4332969 [No Abstract] [Full Text] [Related]
7. Interactions of components of human rhinovirus type 2 with Hela cells. Noble J; Lonberg-Holm K Virology; 1973 Feb; 51(2):270-8. PubMed ID: 4348300 [No Abstract] [Full Text] [Related]
9. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses. Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139 [TBL] [Abstract][Full Text] [Related]
10. The advantages of HeLa cells for isolation of rhinoviruses. Strizova V; Brown PK; Head B; Reed SE J Med Microbiol; 1974 Nov; 7(4):433-8. PubMed ID: 4375193 [No Abstract] [Full Text] [Related]
11. Rhinoviruses. Stott EJ; Killington RA Annu Rev Microbiol; 1972; 26():503-24. PubMed ID: 4343002 [No Abstract] [Full Text] [Related]
12. The effects of hydrogen ions on the morphology and infectivity of rhinovirions. Reeves JD; Mayor HD Arch Gesamte Virusforsch; 1973; 40(3):325-33. PubMed ID: 4121664 [No Abstract] [Full Text] [Related]
13. Factors affecting the growth of Rhinovirus 2 in suspension cultures of L132 cells. Stott EJ; Heath GF J Gen Virol; 1970 Jan; 6(1):15-24. PubMed ID: 4313398 [No Abstract] [Full Text] [Related]
14. Infectivity assays of human rhinovirus-A and -B serotypes. Lee WM; Chen Y; Wang W; Mosser A Methods Mol Biol; 2015; 1221():71-81. PubMed ID: 25261308 [TBL] [Abstract][Full Text] [Related]
15. Effect of isoflavans and isoflavenes on rhinovirus 1B and its replication in HeLa cells. Conti C; Orsi N; Stein ML Antiviral Res; 1988 Nov; 10(1-3):117-27. PubMed ID: 2852916 [TBL] [Abstract][Full Text] [Related]
16. Reproducible plaquing system for rhinovirus serotypes in HeLa cells--agarose suspension. Sethi SK Acta Virol; 1978 Jan; 22(1):60-5. PubMed ID: 25009 [TBL] [Abstract][Full Text] [Related]
17. Physical and metabolic requirements for early interaction of poliovirus and human rhinovirus with HeLa cells. Lonberg-Holm K; Whiteley NM J Virol; 1976 Sep; 19(3):857-70. PubMed ID: 184301 [TBL] [Abstract][Full Text] [Related]